Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |